Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: In vitro release and in vivo skin penetration

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 2, 2003, Pages 240-245

  Miyazaki, Shozo ^a   Takahashi, Akie ^a   Kubo, Wataru ^a   Bachynsky, John ^b   Löbenberg, Raimar ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; DRUG CARRIER; ENBUCRILATE; INDOMETACIN; NANOCAPSULE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE; POLOXAMER; POLYMER; MICROCAPSULE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTHRITIS; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; POLYMERIZATION; RAT; SCANNING ELECTRON MICROSCOPY; SKIN INFLAMMATION; SKIN PENETRATION; STEADY STATE; ANIMAL; CHEMISTRY; MEDICINAL CHEMISTRY; MICROCAPSULE; NANOTECHNOLOGY; SKIN ABSORPTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENBUCRILATE; INDOMETHACIN; NANOTECHNOLOGY; PARTICLE SIZE; POLOXAMER; RATS; SKIN ABSORPTION;

EID: 0141764822     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kreuter J., Nanoparticles. In Colloidal drug delivery systems. Kreuter J.(Eds.) Marvel Dekker, New York, p219-342, 1994.
2. Couvreur, P., Kante, B., Roland, M., Guiot, P., Baudin, P., Speiser, P., Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31, 331-332, 1979.
3. Couvreur, P., Kante, B., Roland, M., Speiser, P., Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. J. Pharm. Sci. 68, 1521-1524, 1979.
4. Couvreur, P., Kante, B., Lenaerts, V., Scailteur, V., Roland, M., Speiser, P., Tissue distribution of anticancer drugs associated to polyalkylcyanoacrylate nanoparticles. J. Pharm. Sci. 69,199-202, 1980.
5. Kante, B., Couvreur, P., Lenaerts, V., Guiot, P., Roland, M., Baudhuin P., Speiser, P., Tissue distribution of 3H-actinomycin D absorbed on polybutyl-cyanoacrylate nanoparticles. Int. J. Pharm. 7, 45-53, 1980.
6. Couvreur, P., Kante, B., Grislain, L., Roland, M., Speiser, P., Toxicity of polyalkylcyanoacrylate nanoparticles. II. Doxorubicin loaded nanoparticles. J. Pharm. Sci. 71, 790-793, 1982.
7. Kreuter, J., Mills, S., N., Davis, S. S., Wilson, C. G., Polybutylcyanoacrylate nanoparticles for the delivery of [75Se] norcholesterol. Int. J. Pharm. 16, 105-113, 1983.
8. El-Samaligy, M. S., Rohdevald, P., Mahmoud, H. A., Polyalkyl cyanoacrylate nanocapsules. J. Pharm. Pharmacol. 31, 216-218, 1986.
9. Damge, C., Michel, C., Aprahamian, M., Couvreur, P., New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37, 246-251, 1988.
10. Allemann, E., Gurny, R., Doelker, E., Drug-loaded nanoparticles preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39, 173-191, 1993.
11. Das, S. K., Tucker, I. G. Hill, D. J., Ganguly, N., Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles. Pharm. Res. 12, 534-540, 1995.
12. Andrieu, V., Fessi, H., Dubrasquet, M., Devissaguet, J-Ph., Puisieux, F., Benita, S., Pharmacokinetic evaluation of indomethacin nanocapsules. Drug Des. Del. 4, 295-302, 1989.
13. Araujo, L., Sheppard, M., Lobenberg, R., Kreuter, J., Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: Modification of the body distribution after suspension in surfactant solutions and in oil vehicles. Int. J. Pharm. 176, 209-224, 1999.
14. Damge, C., Aprahamian, M., Balboni, G., Hoeltzel, A., Andrieu, V., Devissaguet, J-Ph., Polyalkylcyanoacrylate nanocapsules increase the intestinal absorption of a lipophilic drug. Int. J. Pharm. 36, 121-125, 1987.
15. Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, JX., Kissel, T., Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50 147-160, 2000.
16. Harima, T., Kreuter, J., Speiser, P., Boye, T., Gurny, R., Kubis, A., Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutyl-cyanoacrylate nanoparticles. Int. J. Pharm. 33, 187-193, 1986.
17. Alonso M.J., Nanoparticulate drug carrier technology. In Microparticulate systems for the delivery of proteins and vaccines. Cohen S. and Bernstein H. (Eds.) Marvel Dekker, New York, p203-242, 1996.
18. Miyazaki, S., Tobiyama, T., Takada, M., Attwood, D., Percutaneous absorption of indomethacin from pluronic F-127 gels in rats. J. Pharm. Pharmacol. 47, 455-457, 1995.
19. Takahashi, A., Suzuki, S., Kawasaki, N., Kubo, K., Miyazaki, S., Loebenberg, R., Bachynsky, J., Attwood, D., Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats, Int. J. Pharm., 246, 179-186, 2000.
20. Al Khouri Fallouh, N., Roblot-Treupel, L., Fessi, H., Devissaguet, J-Ph., Puisieux, F., Development of a new process for the manufacture of polyisobutyl-cyanoacrylate nanocapsules. Int. J. Pharm. 28, 125-132, 1986.
21. Fawaz, F., Guyot, M., Lagueny, A.M., Devissaguet, J.Ph., Ciproflexan-loaded polyisobutylcyanoacrylate nanoparticles: preparetion and characterization. Int. J. Pharm. 154, 191-203, 1997.
22. Miyazaki, S., Yokouchi, C., Nakamura, T., Hashiguchi, N., Hou, W.-M., Takada, M., Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chem, Pharm. Bull. 34, 1801-1808, 1986.
23. Miyazaki, S., Takeuchi, S., Yokouchi, C., Takada, M., Pluronic F 127 gels as a vehicle for topical administration of anticancer agents. Chem. Pharm. Bull. 32, 4205-4208, 1984.
24. Yamaoka, K., Tanigawa, Y., Nakagawa T., Uno, T., 1981. Pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4, 879-885.
25. Ammoury N., Fessi H., Jean-Philippe Devissaguet J.-P., Allix M., Plotkine M., Boulu R.G., Effect on cerebral blood flow of orally administered indomethacin-loaded poly (isobutylcyanoacrylate) and poly (DL-lactide)nanocapsules. J. Pharm. Pharmacol. 42 558-561, 1990.
26. Rolland, A., Wagner, N., Chatelus, A., Shroot, B., Schaefer, H., 1993. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres, Pharm. Res. 10 1738-1744.
27. de Jaron, E.G., Blanco-Prieto, M.J., Ygartua, P., Santoyo, S., 2001. PLGA microparticles: possible vehicles for topical drug delivery. Int. J. Pharm. 226, 181-184.